Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects

Journal of Clinical Pharmacology

Volumn 42, Issue 9, 2002, Pages 985-994

  Dilger, Karin ^a   Herrlinger, Charlotte ^a   Peters, Jörg ^b   Seyberth, Hannsjörg W ^c   Schweer, Horst ^c   Klotz, Ulrich ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CELECOXIB; DICLOFENAC; INULIN; RENIN; THROMBOXANE B2; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DIAGNOSTIC AGENT; ICOSANOID; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ADULT; AGE; AGED; ANALGESIA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG METABOLISM; DRUG SAFETY; ELDERLY CARE; FEMALE; HUMAN; HUMAN EXPERIMENT; INULIN CLEARANCE; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PATIENT MONITORING; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SIDE EFFECT; URINALYSIS; AGING; COMPARATIVE STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PHYSIOLOGY; PROTEINURIA; TIME; URINE;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DOUBLE-BLIND METHOD; EICOSANOIDS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INULIN; ISOENZYMES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PROTEINURIA; PYRAZOLES; RENIN-ANGIOTENSIN SYSTEM; SULFONAMIDES; TIME FACTORS;

EID: 0036708025     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270002042009005     Document Type: Article

References (51)

1. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
2. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
3. The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency
4. Nonsteroidal anti-inflammatory drugs and hypertension: The risks in perspective
5. Role of renal prostaglandins in the control of renin release
6. Prostaglandins and renin production: A review
7. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
8. Celecoxib, a COX-2-specific inhibitor: The clinical data
9. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
10. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
11. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
12. COX-2 selective nonsteroidal anti-inflammatory drugs: Do they really offer any advantage?
13. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
14. Nonsteroidal anti-inflammatory drugs and antihypertensives
15. NSAIDs and blood pressure: Clinical importance for older patients
16. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications
17. Analgesic abuse in the elderly: Renal sequelae and management
18. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons
19. Effects of aging and drugs on normal renal function
20. Effects of celecoxib and naproxen on renal function in the elderly
21. Are selective COX-2 inhibitors nephrotoxic?
22. NSAIDs and the kidney revisited: Are selective cyclooxygenase-2 inhibitors safe?
23. Renal effects of selective cyclooxygenase-2 inhibition in normotensive saltdepleted subjects
24. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet
25. Guidelines for the management of hypertension. Guidelines subcommittee
26. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects
27. Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex
28. How to assess glomerular function and damage in humans
29. Diagnostic strategies in urinalysis
30. Sinistrin clearance for determination of glomerular filtration rate: A reappraisal of various approaches using a new analytical method
31. First international reference preparation for individual proteins in urine. IFCC working group on urine proteins
32. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry
33. COX-2 and the kidneys
34. The coxibs, selective inhibitors of cyclooxygenase-2
35. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
36. Nonsteroidal anti-inflammatory drugs and hypertension in the elderly: A community-based cross-sectional study
37. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population
38. Effect of indomethacin on blood pressure control during treatment with nitrendipine
39. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
40. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet
41. Effect of age on the renin-angiotensin-aldosterone system in normal subjects: Simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma
42. Changes in the renin-angiotensinaldosterone axis in later life
43. Renal handling of drugs in the healthy elderly
44. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS Study: A randomized controlled trial
45. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial survival
46. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
47. Clinical assessment of renal and systemic prostanoid activity
48. 2α ratio as a marker for seminal fluid contamination of urine in studies of renal prostaglandin biosynthesis
49. Selective cyclooxygenase-2 inhibition by nimesulide in man
50. Effects of celecoxib and naproxen on renal function in chronic renal insufficiency patients
51. Cyclooxygenase products and atherothrombosis